EDGAR Filing Documents for 0001723963-17-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001723963-17-000001

Filing Date

2017-11-29

Accepted

2017-11-29 16:16:23

Documents

Effectiveness Date

2017-11-29

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	5690
	Complete submission text file	0001723963-17-000001.txt		6748

Mailing Address 621 HUTTON STREET SUITE 104 RALEIGH NC 27606

Business Address 621 HUTTON STREET SUITE 104 RALEIGH NC 27606 919-513-6157

BreStem Therapeutics, Inc. (Filer) CIK: 0001723963 (see all company filings)